| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/12/2000 | EP1017380A1 Topical non-steroidal anti-inflammatory drug composition |
| 07/12/2000 | EP1017379A1 Therapeutic compositions |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | EP1017377A2 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions |
| 07/12/2000 | EP1017376A1 Method of treating heart failure |
| 07/12/2000 | EP1017375A2 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 07/12/2000 | EP1017374A2 G2 checkpoint inhibitors and assay |
| 07/12/2000 | EP1017371A4 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017371A1 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017370A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| 07/12/2000 | EP1017368A2 Self-binding shearform compositions |
| 07/12/2000 | EP1017366A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 07/12/2000 | EP1017365A1 Liposome-entrapped polynucleotide composition and method |
| 07/12/2000 | EP1017364A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 07/12/2000 | EP1017363A1 Taste masking for unpalatable formulations |
| 07/12/2000 | EP1017353A2 Therapeutic process for inhibiting nf-kappa b |
| 07/12/2000 | EP1017279A1 Methods for regulating trka expression |
| 07/12/2000 | EP1017278A2 Use of quaternary carboxylic acid alkanolamine ester salts as microbicide agents |
| 07/12/2000 | EP1017275A1 Polyamine treatment of neurological disorders |
| 07/12/2000 | EP0934071A4 Non-aqueous colonic purgative formulations |
| 07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
| 07/12/2000 | EP0822932B1 Piperidine derivatives as diuretic |
| 07/12/2000 | EP0798971B1 Increasing creatine and glycogen concentration in muscle |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0745073B1 5-substituted derivatives of mycophenolic acid |
| 07/12/2000 | EP0731802B1 N-substituted azabicycloalkane derivatives as neuroleptics etc. |
| 07/12/2000 | EP0720600B1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 07/12/2000 | EP0719772B1 Optically active imidazolidinone derivative and process for producing the same |
| 07/12/2000 | EP0690854B1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 07/12/2000 | EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 07/12/2000 | EP0642342B1 Selective cell inactivation in blood |
| 07/12/2000 | EP0628041B1 Heterocyclic compounds and their preparation and use |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | EP0561850B1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 07/12/2000 | EP0555391B1 Certain imidazoquinoxalines; a new class of gaba brain receptor ligands |
| 07/12/2000 | EP0543811B1 Topical treatment of blepharitis |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1259998A Modified retinoblastoma tumor suppressor protein |
| 07/12/2000 | CN1259956A Novel 4-Halogenated steroids prepn. method and intermediates, application as medicines and pharmaceutical compositions contg. same |
| 07/12/2000 | CN1259955A C-4'-substituted macrolide derivatives |
| 07/12/2000 | CN1259954A 3-substituted pyrido [3',4' : 4,5] thieno [2,3D} pyrimidine derivatives, prodn. and use thereof |
| 07/12/2000 | CN1259952A Carbostyril carboxylic acid derivatives |
| 07/12/2000 | CN1259951A Novel pharmaceutically useful compounds |
| 07/12/2000 | CN1259950A Pyrrolo [2,3D] pyrimidines and their use as tyrosine kinase inhibitors |
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259947A 2-aryl-naphthyridin-4-ones as antitumor agent |
| 07/12/2000 | CN1259946A Ergoline derivatives and their use as somatostatin receptor antagonists |
| 07/12/2000 | CN1259945A Prevention of breast cancer with selective estrogen receptor modulators |
| 07/12/2000 | CN1259944A Treatments of prophylaxis of prostatic cancer and benign prostatic hyperplasia |
| 07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
| 07/12/2000 | CN1259941A Process for mfg. racemic compound |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259938A Crambescidin compound |
| 07/12/2000 | CN1259872A NKT cell activators contg. alpha-glycosylceramides |
| 07/12/2000 | CN1259871A Method of treating chronic progressive vascular scarring diseases |
| 07/12/2000 | CN1259870A Fatty emulsing contg. reducing sugar and method for sterilizing same |
| 07/12/2000 | CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 07/12/2000 | CN1259868A Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for treating cancer |
| 07/12/2000 | CN1259867A Use of bis-1,2,4-triazoles for mfg. medicament for treating cancers |
| 07/12/2000 | CN1259866A Therapeutic treatment for skin disorders |
| 07/12/2000 | CN1259865A Use of docosahexanoic acid arachidonic acid enhancing the growth of preterm infants |
| 07/12/2000 | CN1259864A Rapamycin formulations for oral administration |
| 07/12/2000 | CN1259863A Therapeutically active compositions |
| 07/12/2000 | CN1259520A Adriamycin polybasic acid sodium salt complex salt |
| 07/12/2000 | CN1259517A Method for preparing 2,5-diamino-4,6-dichloropyrimidine |
| 07/12/2000 | CN1259386A Isoniazid synergistic compound aerosol and its prepn. method |
| 07/12/2000 | CN1259376A Medicinal liquid for treating bone fracture |
| 07/12/2000 | CN1259368A Medicine for treating gastritis, gastric ulcer and duodenal ulcer and its prepn. method |
| 07/12/2000 | CN1259364A Medicinal composition for treating stomach and intestine ulcer |
| 07/12/2000 | CN1259361A Chinee medicinal power for treating toothache and its prepn. method |
| 07/12/2000 | CN1259349A Sealwort polysaccharide wine |
| 07/12/2000 | CN1259348A Sealwort polysaccharide konjaku glucomannan capsule |
| 07/12/2000 | CN1259347A Polyether medicine used for antituberculosis and antileprosy |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |
| 07/12/2000 | CN1259345A Prodn. method of paired two kind units penicillin sodium powde used for injection |
| 07/12/2000 | CN1259343A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1259342A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1259285A Disinfectant powder for feet and its preparing method |
| 07/12/2000 | CN1054382C Reversed phase preparative liquid chromatography for extracting and purifying taxol |
| 07/12/2000 | CN1054381C Taxane having antitumor activity, mfg. method and pharmaceutical compositions thereof |
| 07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
| 07/12/2000 | CN1054379C Analgesic compounds and their prepn. and their use |
| 07/12/2000 | CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/12/2000 | CN1054376C Substituted 1H-imidazoles |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/12/2000 | CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same |
| 07/12/2000 | CN1054372C Amino substituted benzosulfonylurea and -thiorea prepn. and pharmaceutical use of same |
| 07/12/2000 | CN1054284C Natural skin-care raw material-saussurea involucrata extract of alcohol |
| 07/12/2000 | CN1054282C Stabilized medicinal aerosol solution formulations |
| 07/11/2000 | US6087509 Derivatives of trifluorobenzonitriles |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087496 Enzyme inhibitors |
| 07/11/2000 | US6087479 Introducing into patient a medical device of which at least a portion includes a nitric oxide adduct which may be a sodium nitroprusside, a nitrosothiol, a nitrate, a nitrite or a nitrosated amino acid |
| 07/11/2000 | US6087477 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 07/11/2000 | US6087401 Heating uronic acid compound |
| 07/11/2000 | US6087400 Mixture containing benzalkonium chloride and water |
| 07/11/2000 | US6087399 Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them |
| 07/11/2000 | US6087398 Sickle cell anemia treatment |
| 07/11/2000 | US6087396 A stable aqueous oxybutynin chloride solution can be placed in an infuser device for treatment of bladder dysfunction |
| 07/11/2000 | US6087394 Compositions, apparatus and methods for facilitating surgical procedures |